Phibro Animal Health (PAHC) Total Current Liabilities (2013 - 2026)
Phibro Animal Health (PAHC) posted Total Current Liabilities of $316.5 million for Q2 2026, up 12.27% on a QoQ basis from $281.9 million in Q1 2026, and up 7.84% year-over-year from $293.5 million in Q2 2025.
Analysis
Phibro Animal Health (PAHC) Total Current Liabilities (2013 - 2026) Analysis & Trends
Phibro Animal Health has reported Total Current Liabilities for 14 years, with the latest figure at $316.5 million in Q2 2026.
- On a quarterly basis, Total Current Liabilities rose 7.84% year-over-year to $316.5 million in Q2 2026; TTM through Jun 2026 was $316.5 million, a 7.84% increase from a year earlier, with the FY2026 full-year figure at $316.5 million, up 7.84% from the prior year.
- Total Current Liabilities was $316.5 million for Q2 2026 at Phibro Animal Health, up from $281.9 million in the prior quarter.
- The five-year high for Total Current Liabilities was $316.5 million in Q2 2026, with the low at $165.3 million in Q1 2023.
- Average Total Current Liabilities over 5 years is $218.5 million, with a median of $190.0 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities fell 11.65% in 2023, then soared 52.71% in 2025.
- Over 5 years, Total Current Liabilities stood at $167.6 million in 2022, then grew by 12.03% to $187.7 million in 2023, then rose by 24.24% to $233.2 million in 2024, then gained by 21.06% to $282.4 million in 2025, then climbed by 12.08% to $316.5 million in 2026.
- The last three Total Current Liabilities figures came in at $316.5 million (Q2 2026), $281.9 million (Q1 2026), and $282.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | 1.29 Bn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 2.06 Bn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 1.85 Bn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 316.47 Mn |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | 4.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | 16.99 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 7,791.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 316.47 Mn |
| Mar 31, 2026 | 281.87 Mn |
| Dec 31, 2025 | 282.37 Mn |
| Sep 30, 2025 | 270.14 Mn |
| Jun 30, 2025 | 293.47 Mn |
| Mar 31, 2025 | 266.48 Mn |
| Dec 31, 2024 | 233.25 Mn |
| Sep 30, 2024 | 176.89 Mn |
| Jun 30, 2024 | 204.15 Mn |
| Mar 31, 2024 | 189.07 Mn |
| Dec 31, 2023 | 187.74 Mn |
| Sep 30, 2023 | 172.36 Mn |
| Jun 30, 2023 | 176.00 Mn |
| Mar 31, 2023 | 165.31 Mn |
| Dec 31, 2022 | 167.57 Mn |
| Sep 30, 2022 | 172.50 Mn |
| Jun 30, 2022 | 190.83 Mn |
| Mar 31, 2022 | 187.10 Mn |
| Dec 31, 2021 | 166.63 Mn |
| Sep 30, 2021 | 152.59 Mn |